References
- Surveillance, Epidemiology, and End Results Program. Available from: http://seer.cancer.gov/statfacts/html/lungb.html [Last accessed 4 January 2014]
- Surveillance, Epidemiology, and End Results Program. Available from: www.seer.cancer.gov/archive/csr/1975_2008/results_single/sect_15_table.28.pdf [Last accessed 4 January 2014]
- Gross CP, Herrin J, Wong N, Krumholz HM. Enrolling older persons in cancer trials: the effect of sociodemographic, protocol, and recruitment center characteristics. J Clin Oncol 2005;23:4755-63
- Medical Research Council of Great Britain. Comparative trial of surgery and radiotherapy for the primary treatment of small-celled or oat-celled carcinoma of the bronchus. First report to the Medical Research Council by the working-party on the evaluation of different methods of therapy in carcinoma of the bronchus. Lancet 1966;2(7471):979-86
- Green RA, Humphrey E, Close H, Patno ME. Alkylating agents in bronchogenic carcinoma. Am J Med 1969;46(4):515-25
- Hyde L, Yee J, Wilson R, Patno ME. Cell type and the natural history of lung cancer. JAMA 1965;193:52-4
- Simon GR, Wagner H. Small cell lung cancer. Chest 2003;123(1):259S-71S
- Pallis AG, Shepherd FA, Lacombe D, Gridelli C. Treatment of small-cell lung cancer in elderly patients. Cancer 2010;116:1192-200
- National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Available from: www.nccn.org/professionals/physician_gls/pdf/sclc.pdf [Last accessed 4 January 2014]
- Aupérin A, Arriagada R, Pignon JP, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. N Engl J Med 1999;341:476-84
- Eaton BR, Kim S, Marcus DM, et al. Effect of prophylactic cranial irradiation on survival in elderly patients with limited-stage small cell lung cancer. Cancer 2013;119(21):3753-60
- Rossi A, Maione P, Colantuoni G, et al. Treatment of small cell lung cancer in the elderly. Oncologist 2005;10:399-411
- Murata Y, Hirose T, Yamaoka T, et al. Phase II trial of the combination of carboplatin and irinotecan in elderly patients with small-cell lung cancer. Eur J Cancer 2011;47(9):1336-42
- Yuen AR, Zou G, Turrisi AT, et al. Similar outcome of elderly patients in intergroup trial 0096: cisplatin, etoposide, and thoracic radiotherapy administered once or twice daily in limited stage small cell lung carcinoma. Cancer 2000;89(9):1953-60
- Okamoto H, Watanabe K, Kunikane H, et al. Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702. Br J Cancer 2007;97(2):162-9
- Fisher S, Al-Fayea TM, Winget M, et al. Uptake and tolerance of chemotherapy in elderly patients with small cell lung cancer and impact on survival. J Cancer Epidemol 2012;2012:708936
- Caprario LC, Kent DM, Strauss GM. Effects of chemotherapy on survival of elderly patients with small-cell lung cancer: analysis of the SEER-Medicare database. J Thorac Oncol 2013;8:1272-81